Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
TXMD: TherapeuticsMD, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
TXMD
The Story
TXMD
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+71.6% / yr
Operating margin
-111.7%
ROIC
-8.1%
Financially safe
Stretched
Debt / equity
0.22×
Interest coverage
-624.0×
Current ratio
3.11×
Valuation
Unrated
P/E ratio
131.8×
TherapeuticsMD, Inc.
TXMD
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
TherapeuticsMD, Inc.
TXMD
NASDAQ
·
USD
·
Closed
$2.03
+0.00%
$2.03
+$0.00 (0.00%)
52W Range
53th
pctl
Volume
0.24×
avg
Mkt Cap
23.50M
USD
P/E
131.8
TTM
Div Yield
–
ann
52W Range
53th
pctl
Volume
0.24×
avg
Market Cap
23.50M
USD
P/E Ratio
131.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings